Myeloproliferative Neoplasms

Top Story

Lack of transfusion capabilities linked to underuse of hospice for blood cancers

May 22, 2017

Hematologic oncologists appeared to value hospice but may be concerned about the adequacy of services like transfusion for patients with blood cancers, thus limiting referrals, according to study results published in Cancer.

“Our findings are important as they shed light on factors that are potential barriers to hospice referrals,” Oreofe O. Odejide, MD, instructor of medicine at Harvard Medical School and physician at Dana-Farber Cancer Institute, said in a press release. “These findings can be employed to develop targeted interventions to address hospice underuse for patients with blood cancers.”

In the Journals Plus

Rare cancers represent 20% of US cancer diagnoses

May 19, 2017
Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society report published in…

ASH announces physician–scientist career development award recipients

May 8, 2017
Two medical students received the 2017-2018 ASH Physician–Scientist Career Development Award. The award helps students attending accredited medical schools in the…

Leukemia & Lymphoma Society panel explores ‘tsunami’ of financial burdens, potential of immunotherapy

May 3, 2017
Patients continue to face a “tsunami” of financial burdens associated with cancer care, but advances in immunotherapy and precision medicine offer much…
CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately…
More »
Video
Meeting News Coverage

Video: Researchers ‘eagerly await’ final data on pegylated interferon for myeloproliferative neoplasms

December 14, 2016
More »
Featured
Oncology Nursing Society Annual Congress

Oncology Nursing Society Annual Congress

CME

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

This activity is supported by an educational grant from Merck & Co, Inc.

The development and integration of targeted therapies, as well as immunotherapies, into clinical strategies for the…
More »
In the Journals Plus

Lack of transfusion capabilities linked to underuse of hospice for blood cancers

May 22, 2017
Hematologic oncologists appeared to value hospice but may be concerned about the adequacy of services like transfusion for patients with blood…

In the Journals Plus

Rare cancers represent 20% of US cancer diagnoses

May 19, 2017
Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society…

ASH announces physician–scientist career development award recipients

May 8, 2017
Two medical students received the 2017-2018 ASH Physician–Scientist Career Development Award. The award helps students attending accredited…

Leukemia & Lymphoma Society panel explores ‘tsunami’ of financial burdens, potential of immunotherapy

May 3, 2017
Patients continue to face a “tsunami” of financial burdens associated with cancer care, but advances in immunotherapy and precision…

FDA News

FDA approves midostaurin for FLT3–mutated AML, other blood disorders

April 28, 2017
The FDA approved midostaurin as part of combination treatment for adults with newly diagnosed FLT3–positive acute myeloid leukemia…

FDA News

FDA issues warnings about fraudulent cancer treatments

April 25, 2017
The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or…

Eight noteworthy FDA actions

April 21, 2017
The FDA announced several decisions related to hematology and oncology therapies and devices in the past month. HemOnc Today summarizes…

Patient education pivotal when recommending palliative care

April 12, 2017
Patients with cancer who are educated about the benefits of palliative care are more likely to consider incorporating it into their treatment…

FDA News

FDA grants marketing authorization to genomic sequencing kit for suspected polycythemia vera

April 10, 2017
The FDA granted marketing authorization to ipsogen JAK2 RGQ PCR Kit for the detection of mutations affecting the JAK2 gene, according to the…

In the Journals Plus

Physician-aided deaths continue to rise in Oregon

April 6, 2017
The number of prescriptions written for physician-aided deaths in Oregon has increased annually since it became the first state to enact the Death…

More Headlines »
Advertisement
Advertisement